Zixin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zixin Wang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yin Wang
Engineering Research Center of Cell & Therapeutic Antibody, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China
4 shared publications - Yuxuan Ge
Shanghai Jiao Tong University
4 shared publications - Fan Rong
Shanghai Jiao Tong University
3 shared publications - Junsheng Chen
Shanghai Jiao Tong University
3 shared publications - Yujia Lu
Shanghai Jiao Tong University
3 shared publications - Bin Hao
Shanghai Jiao Tong University
2 shared publications
Latest Publications
- Open Access
- 13 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Curcumin Driven Formation of Self-Cascade Nanoclusters from Urate Oxidase-H2S Donor Conjugates for Acute Gouty Arthritis Alleviation
Gouty arthritis (GA) is a common arthritis characterized by abnormal deposition of monosodium urate (MSU) crystals in articular structures. Current clinical medications can only alleviate the inflammation caused by the acute GA temporarily, but have no solution to the deposition of MSU. To surmount this, urate oxidase (UOx) was initially modified with the phenylboronic acid-based self-immolative thiocarbamate through nucleophilic substitution, and then co-assembled with curcumin through boronate bond to form the platform (termed UBC). This way, the platform could not only directly eliminate the MSU, but also release the therapeutic gas hydrogen sulfide (H2S) triggered by the toxic by-product of UOx catalysis, hydrogen peroxide (H2O2). Synergized with curcumin, the inflammation could be effectively suppressed. In vivo experiments on an acute GA murine model also validated the potent therapeutic effect of the platform, mainly due to the synergistic effect of H2S and curcumin. We believe this strategy provides a novel approach for the treatment of inflammation-related diseases and novel insight into the construction of multi-functional therapeutic nanomaterials from enzymes and other biomolecules.
- 13 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCurcumin Driven Formation of Self-Cascade Nanoclusters from Urate Oxidase-H2S Donor Conjugates for Acute Gouty Arthritis Alleviation
Gouty arthritis (GA) is a common arthritis characterized by abnormal deposition of monosodium urate (MSU) crystals in articular structures. Current clinical medications can only alleviate the inflammation caused by the acute GA temporarily, but have no solution to the deposition of MSU. To surmount this, urate oxidase (UOx) was initially modified with the phenylboronic acid-based self-immolative thiocarbamate through nucleophilic substitution, and then co-assembled with curcumin through boronate bond to form the platform (termed UBC). This way, the platform could not only directly eliminate the MSU, but also release the therapeutic gas hydrogen sulfide (H2S) triggered by the toxic by-product of UOx catalysis, hydrogen peroxide (H2O2). Synergized with curcumin, the inflammation could be effectively suppressed. In vivo experiments on an acute GA murine model also validated the potent therapeutic effect of the platform, mainly due to the synergistic effect of H2S and curcumin. We believe this strategy provides a novel approach for the treatment of inflammation-related diseases and novel insight into the construction of multi-functional therapeutic nanomaterials from enzymes and other biomolecules.
- Open Access
- 21 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Synergistic metabolism intervention and immune activation for antitumor therapy by biomineralized lactate oxidase
Depleting tumoral lactate is a promising strategy to enhance the immune response and thereby suppressing tumorigenesis. However, the direct use of lactate oxidase (LOx), the most straightforward lactate-eliminating agent, faces several issues including low stability, no targeting capacity. To solve these problems, a “carrier-free” nanodrug LOx@manganese sulfide (LOx@MnS) was facilely prepared via biomineralization. This way, all the constituents integrated in the nanodrug, including LOx, Mn2+, and hydrogen sulfide (H2S), could be readily delivered into tumor cells and exert their effects. LOx combined with Mn2+ to convert lactate to cytotoxic reactive oxygen species (ROS) through the cascade reaction, meanwhile the crosstalk between H2S and ROS induced metabolism suppression to further augment the therapeutic efficacy. Consequently, the multi-mode therapeutic modalities led to effective immune activation and tumor suppression, suggesting the great potential for tumor treatment. We believe this strategy opens a new avenue to construct functional materials from frangible biomolecules and expand their applications.
- 21 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessSynergistic metabolism intervention and immune activation for antitumor therapy by biomineralized lactate oxidase
Depleting tumoral lactate is a promising strategy to enhance the immune response and thereby suppressing tumorigenesis. However, the direct use of lactate oxidase (LOx), the most straightforward lactate-eliminating agent, faces several issues including low stability, no targeting capacity. To solve these problems, a “carrier-free” nanodrug LOx@manganese sulfide (LOx@MnS) was facilely prepared via biomineralization. This way, all the constituents integrated in the nanodrug, including LOx, Mn2+, and hydrogen sulfide (H2S), could be readily delivered into tumor cells and exert their effects. LOx combined with Mn2+ to convert lactate to cytotoxic reactive oxygen species (ROS) through the cascade reaction, meanwhile the crosstalk between H2S and ROS induced metabolism suppression to further augment the therapeutic efficacy. Consequently, the multi-mode therapeutic modalities led to effective immune activation and tumor suppression, suggesting the great potential for tumor treatment. We believe this strategy opens a new avenue to construct functional materials from frangible biomolecules and expand their applications.
- Open Access
- 5 December 2023
- Published by American Chemical Society (ACS) in ChemRxiv
An integrated ROS booster: Hydrogen sulfide-donating nanoclusters designed for multi-mode breast cancer treatment
Nanomaterial-assisted chemodynamic cancer therapy has received considerable attention in recent years. It outperforms other modalities for its unique pattern of reactive oxygen species (ROS) production via the non-exogenous stimulant. However, the treatment outcome is limited by the insufficient content of endogenous hydrogen peroxide (H2O2). Herein, a biodegradable H2S-releasing MnS@HA-DOX nanocluster (MnS@HA-DOX NC) was constructed by in situ biomineralization from hyaluronic acid, to amplify ROS cascade and boost Mn2+-based chemodynamic therapy (CDT). The acid-responsive NCs could quickly degrade after internalization into endo/lysosomes, releasing Mn2+, H2S gas, and anticancer drug doxorubicin (DOX). The Fenton-like reaction catalyzed by Mn2+ was amplified by both H2S and DOX, producing a mass of cytotoxic ·OH radicals. Through the combined action of gas therapy (GT), CDT, and chemotherapy, oxidative stress would be synergistically amplified, inducing irreversible DNA damage and cell cycle arrest, eventually resulting in cancer cell apoptosis.
- 5 December 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAn integrated ROS booster: Hydrogen sulfide-donating nanoclusters designed for multi-mode breast cancer treatment
Nanomaterial-assisted chemodynamic cancer therapy has received considerable attention in recent years. It outperforms other modalities for its unique pattern of reactive oxygen species (ROS) production via the non-exogenous stimulant. However, the treatment outcome is limited by the insufficient content of endogenous hydrogen peroxide (H2O2). Herein, a biodegradable H2S-releasing MnS@HA-DOX nanocluster (MnS@HA-DOX NC) was constructed by in situ biomineralization from hyaluronic acid, to amplify ROS cascade and boost Mn2+-based chemodynamic therapy (CDT). The acid-responsive NCs could quickly degrade after internalization into endo/lysosomes, releasing Mn2+, H2S gas, and anticancer drug doxorubicin (DOX). The Fenton-like reaction catalyzed by Mn2+ was amplified by both H2S and DOX, producing a mass of cytotoxic ·OH radicals. Through the combined action of gas therapy (GT), CDT, and chemotherapy, oxidative stress would be synergistically amplified, inducing irreversible DNA damage and cell cycle arrest, eventually resulting in cancer cell apoptosis.
- Open Access
- 7 May 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Hydrogen sulfide-releasing nanocascade templated by glucose oxidase for diabetic infection treatment
Diabetic ulcer receives much attention in recent years due to its high incidence and mortality, promoting the scientific community to develop various strategies for such chronic disease treatments. However, the therapeutic outcome of these approaches is highly compromised by the invasive bacteria and severe inflammatory ulcer microenvironment. To overcome these dilemmas, microenvironment-responsive self-delivery GOx@MnS nanoparticles (NPs) are developed by a one-step biomineralization. When encountered with high glucose level in the ulcer site, GOx catalyze glucose to decrease the local pH and trigger the steady release of both manganese ions (Mn2+) and hydrogen sulfide (H2S). Mn2+ react with hydrogen peroxide to generate hydroxyl radical for the elimination of bacterial infection, meanwhile H2S is able to suppress the inflammatory response and accelerate diabetic wound healing through macrophage polarization. The excellent biocompatibility, strong bactericidal activity, and considerable immunomodulatory effect promise GOx@MnS NPs great therapeutic potential for diabetic wound treatment.
- 7 May 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessHydrogen sulfide-releasing nanocascade templated by glucose oxidase for diabetic infection treatment
Diabetic ulcer receives much attention in recent years due to its high incidence and mortality, promoting the scientific community to develop various strategies for such chronic disease treatments. However, the therapeutic outcome of these approaches is highly compromised by the invasive bacteria and severe inflammatory ulcer microenvironment. To overcome these dilemmas, microenvironment-responsive self-delivery GOx@MnS nanoparticles (NPs) are developed by a one-step biomineralization. When encountered with high glucose level in the ulcer site, GOx catalyze glucose to decrease the local pH and trigger the steady release of both manganese ions (Mn2+) and hydrogen sulfide (H2S). Mn2+ react with hydrogen peroxide to generate hydroxyl radical for the elimination of bacterial infection, meanwhile H2S is able to suppress the inflammatory response and accelerate diabetic wound healing through macrophage polarization. The excellent biocompatibility, strong bactericidal activity, and considerable immunomodulatory effect promise GOx@MnS NPs great therapeutic potential for diabetic wound treatment.